Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
life sciences
medicaid
3
×
national blog main
national top stories
novartis
3
×
bill cassidy
biotech
boston blog main
boston top stories
cancer
clinical trials
gene therapy
johnson & johnson
mark warner
meiragtx
national
new york blog main
new york top stories
pfizer
roche
spark therapeutics
spinal muscular atrophy
zolgensma
abiraterone
ac immune
achromatopsia
acorda therapeutics
acquisitions
aduro biotech
advanced therapies
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
apalutamide
atmp
atypical hemolytic uremic syndrome
avexis
What
gene
3
×
therapy
access
advanced
age
alzheimer’s
bigger
biggest
bio
capacity
car
cell
come
companies
consolidation
crispr
deal
different
drug
emerging
fail
falcon
focus
gave
increases
j
johnson
latest
meiragtx
milestones
morning
past
patient
pharmaceutical
plan
powered
prescription
price
prices
proactive
Language
unset
Current search:
novartis
×
gene
×
medicaid
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy